Vaccine – Volume 39, Supplement 1
High Dose Influenza Vaccine: Ten Years of Evidence
This publication was produced with support from Sanofi Pasteur. Manuscripts were accepted after rigorous peer review process that was managed by an expert Guest Editor independently appointed by the Editor-in-Chief. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of Sanofi Pasteur. No responsibility is assumed by the Publisher nor by the Sponsor for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, or products liability, whether resulting from negligence or otherwise, or from any use or operation of any ideas, instructions, procedures, products or methods contained in the material therein.
Pages A1-A70 (15 March 2021)